<DOC>
	<DOCNO>NCT01622478</DOCNO>
	<brief_summary>Sentinel lymph node biopsy ( SLNB ) neoadjuvant chemotherapy ( NAC ) currently debatable . It possible tumor response chemotherapy may alter lymphatic drainage thus cause low SLN identification rate high false negative rate . Further , response NAC different lymph node . It doubtful whether SLNB accurately predict axillary lymph node ( ALN ) status NAC . The aim study determine identification rate , false-negative rate , accuracy SLNB NAC node positive breast cancer .</brief_summary>
	<brief_title>Validity Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Advanced breast cancer patient nodepositive prove preoperative imaging study ECOG status 01 No previous cancer history No previous chemotherapy history</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>sentinel lymph node biopsy</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>locally advanced breast cancer</keyword>
	<keyword>positive axillary lymph node</keyword>
	<keyword>negative conversion</keyword>
</DOC>